Second solid cancers in patients treated with allogeneic haematopoietic cell transplantation using reduced intensity/non-myeloablative conditioning regimens: a Center for International Blood and Marrow Transplant Research study

Authors

O. Ringden, Karolinska Institute
R. Brazauskas, Center for Blood and Marrow Transplant Research, Milwaukee, WI
Z. Wang, Center for Blood and Marrow Transplant Research, Milwaukee, WI
C. Duncan, Dana Farber Cancer Institute, Boston, MAFollow
David Jacobsohn, George Washington UniversityFollow
J. Mattson, Karolinska Institute
M. Sorror, Fred Hutchinson Cancer Research Center, Seattle, WA
N. Majhail, National Bone Marrow Donor Program, Minneapolis, MN

Document Type

Journal Article

Publication Date

4-2013

Journal

Bone Marrow Transplantation

Volume

Volume 48, Supplement 2

Inclusive Pages

S60

APA Citation

Ringden, O., Brazauskas, R., Wang, Z., Duncan, C., Jacobsohn, D., Mattsson, J., Sorror, M., Majhail, N. (2013). Second solid cancers in patients treated with allogeneic haematopoietic cell transplantation using reduced intensity/non-myeloablative conditioning regimens: a Center for International Blood and Marrow Transplant Research study. Bone Marrow Transplantation, 48(2), S60.

Peer Reviewed

1